SEDALOR

This brand name is authorized in Austria, Cyprus, Malta

Active ingredients

The drug SEDALOR contains one active pharmaceutical ingredient (API):

1 Lormetazepam UNII GU56C842ZA - LORMETAZEPAM

Lormetazepam is a benzodiazepine with anxiolytic, muscle relaxant, sedative and hypnotic properties. Clinical studies have shown minimal effects on REM sleep and on psychomotor performance on the day after treatment with lormetazepam. Lormetazepam is indicated for the short term treatment of insomnia. Read about Lormetazepam

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
SEDALOR Solution for injection / infusion		MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N05CD06	Lormetazepam	N Nervous system → N05 Psycholeptics → N05C Hypnotics and sedatives → N05CD Benzodiazepine derivatives
Discover more medicines within N05CD06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: MT	Medicines Authority	Identifier(s): MA1080/00101